On this episode of A&M Conversation With, Senior Director Maria Nizza, from Alvarez & Marsal’s Valuation Services, discusses changes in the collateralized loan obligation market over the last 12 months, and what we should consider when valuing of CLOs.

On this episode of A&M Conversation With, Managing Directors David Riviere and Keith Browning, as well as Senior Directors Matt Stanfield and Art Hall sit down to discuss the growing digital presence within the supply chain.

On this episode of A&M Conversation With Managing Directors Richard Bibby and Mark McMahon converse with Ian Blance of Voltaire Advisors about factors PE fund managers take into consideration when thinking about outsourcing valuation.

On this episode of A&M Conversation With Managing Directors Richard Bibby and Mark McMahon converse with Ian Blance of Voltaire Advisors to identify some of the changes and issues that will affect valuation in PE Funds.

On this episode of A&M Conversation With, Managing Director Dr. David Gruber sits down with Managing Director Jay Burkett to discuss the essentials of risk management.

Patient engagement is critical, as behavioral (lifestyle) and social circumstances represent 40 percent and 15 percent, respectively, of the contributors to premature death. Patient engagement requires self-management and supportive provider and/or payer interventions.

On this episode of A&M Conversation With, Managing Director Dr. David Gruber sits down with Mark Finucane, Managing Director and Co-head of West Coast operations to discuss the need for risk stratification, and the impact of co-morbid depression, activity limitations and social determinants on the total cost of care.

On this episode of A&M Conversation With, Managing Director Dr. David Gruber sits down with Managing Director Stuart McLean to discuss the U.S. healthcare delivery system in terms cost, effectiveness and the barriers to the coordinated care delivery system.

Michael O’Dowd, a Managing Director with A&M’s Transaction Advisory Group, Managing Director Jeffrey Klein of the Private Equity Performance Improvement Group and Managing Director Art Ehuan of the Disputes and Investigations Group to discuss cybersecurity during the exit stage and the technical testing that is required to identify vulnerabilities.

Michael O’Dowd, a Managing Director with A&M’s Transaction Advisory Group sits down with Managing Directors Jeffrey Klein of the Private Equity Performance Improvement Group and Art Ehuan of the Disputes and Investigations Group to discuss the importance of assessing cyber during the post-acquisition stage.

Michael O’Dowd, a Managing Director with A&M’s Transaction Advisory Group sits down with Managing Directors Jeffrey Klein of the Private Equity Performance Improvement Group and Art Ehuan of the Disputes and Investigations Group to discuss the importance of assessing cyber during the pre-acquisition stage.

In this podcast episode, Managing Director David Gruber sits down with Managing Director John Cox to discuss the Senate's healthcare reform proposal and address the substance abuse epidemic.

On this episode of A&M Conversation With, Valuation Services, Senior Directors Brent Sloan and Robert Pay discuss the election of accounting alternatives for intangible assets acquired in business combinations and subsequent goodwill impairment testing.

In Part 1 of this podcast series, Corporate Performance Improvement Senior Director Art Hall sits down with John Kiger, Vice President of Technology Risk Management at PHH to discuss rapid change in artificial intelligence (AI) and its role in third party risk management.

Dr. David Gruber sits down with Managing Directors Peter Urbanowicz and John Cox to discuss the House of Representatives AHCA vote that has now moved on to the Senate. What will this mean for the future of healthcare?